• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨膜区 GxxxG 二聚化基序的差异配对定义了两种 HLA-DR MHC Ⅱ类构象。

Differential pairing of transmembrane domain GxxxG dimerization motifs defines two HLA-DR MHC class II conformers.

机构信息

Department of Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA.

Transplant Immunology Laboratory, Department of Surgery, Albany Medical College, Albany, New York, USA.

出版信息

J Biol Chem. 2023 Jul;299(7):104869. doi: 10.1016/j.jbc.2023.104869. Epub 2023 May 27.

DOI:10.1016/j.jbc.2023.104869
Abstract

MHC class II molecules function to present exogenous antigen-derived peptides to CD4 T cells to both drive T cell activation and to provide signals back into the class II antigen-presenting cell. Previous work established the presence of multiple GxxxG dimerization motifs within the transmembrane domains of MHC class II α and β chains across a wide range of species and revealed a role for differential GxxxG motif pairing in the formation of two discrete mouse class II conformers with distinct functional properties (i.e., M1-and M2-paired I-A class II). Biochemical and mutagenesis studies detailed herein extend this model to human class II by identifying an anti-HLA-DR mAb (Tü36) that selectively binds M1-paired HLA-DR molecules. Analysis of the HLA-DR allele reactivity of the Tü36 mAb helped define other HLA-DR residues involved in mAb binding. In silico modeling of both TM domain interactions and whole protein structure is consistent with the outcome of biochemical/mutagenesis studies and provides insight into the possible structural differences between the two HLA-DR conformers. Cholesterol depletion studies indicate a role for cholesterol-rich membrane domains in the formation/maintenance of Tü36 mAb reactive DR molecules. Finally, phylogenetic analysis of the amino acid sequences of Tü36-reactive HLA-DR β chains reveals a unique pattern of both Tü36 mAb reactivity and key amino acid polymorphisms. In total, these studies bring the paradigm M1/M2-paired MHC class II molecules to the human HLA-DR molecule and suggest that the functional differences between these conformers defined in mouse class II extend to the human immune system.

摘要

MHC II 类分子的功能是将外源性抗原衍生肽呈递给 CD4 T 细胞,从而既能驱动 T 细胞激活,又能向 II 类抗原呈递细胞提供信号。先前的工作已经在广泛的物种中证实了 MHC II 类 α 和 β 链跨膜结构域中存在多个 GxxxG 二聚化基序,并揭示了不同 GxxxG 基序配对在形成两种具有不同功能特性的离散鼠类 II 类构象体中的作用(即 M1-和 M2-配对的 I-A 类 II 类)。本文详细的生化和突变研究将该模型扩展到人类 II 类,鉴定了一种抗 HLA-DR mAb(Tü36),该 mAb 特异性结合 M1-配对的 HLA-DR 分子。对 Tü36 mAb 对 HLA-DR 等位基因反应性的分析有助于确定其他涉及 mAb 结合的 HLA-DR 残基。TM 结构域相互作用和整个蛋白质结构的计算机建模与生化/突变研究的结果一致,并为理解两种 HLA-DR 构象体之间可能的结构差异提供了线索。胆固醇耗竭研究表明富含胆固醇的膜结构域在 Tü36 mAb 反应性 DR 分子的形成/维持中起作用。最后,对 Tü36 反应性 HLA-DRβ链的氨基酸序列进行系统发育分析揭示了 Tü36 mAb 反应性和关键氨基酸多态性的独特模式。总的来说,这些研究将 M1/M2-配对的 MHC II 类分子的范例扩展到人类 HLA-DR 分子,并表明在鼠类 II 类中定义的这些构象体之间的功能差异扩展到人类免疫系统。

相似文献

1
Differential pairing of transmembrane domain GxxxG dimerization motifs defines two HLA-DR MHC class II conformers.跨膜区 GxxxG 二聚化基序的差异配对定义了两种 HLA-DR MHC Ⅱ类构象。
J Biol Chem. 2023 Jul;299(7):104869. doi: 10.1016/j.jbc.2023.104869. Epub 2023 May 27.
2
A triad of molecular regions contribute to the formation of two distinct MHC class II conformers.三个分子区域共同促成了两种不同的MHC II类构象体的形成。
Mol Immunol. 2016 Jun;74:59-70. doi: 10.1016/j.molimm.2016.04.010. Epub 2016 May 2.
3
Signaling Cross-Talk between MHC Class II Molecular Conformers in Resting Murine B Cells.静息小鼠B细胞中MHC II类分子构象体之间的信号串扰
Immunohorizons. 2019 Jan 18;3(1):28-36. doi: 10.4049/immunohorizons.1800078.
4
Differential transmembrane domain GXXXG motif pairing impacts major histocompatibility complex (MHC) class II structure.跨膜结构域 GXXXG 基序对的差异影响主要组织相容性复合体(MHC)II 类结构。
J Biol Chem. 2014 Apr 25;289(17):11695-11703. doi: 10.1074/jbc.M113.516997. Epub 2014 Mar 11.
5
Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.假定的MHC II类“二聚体的二聚体”界面中的氨基酸取代抑制CD4 + T细胞活化。
J Immunol. 2001 Jan 15;166(2):800-8. doi: 10.4049/jimmunol.166.2.800.
6
In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.在缺乏内源性MHC I类和/或II类表达的HLA - DQ或HLA - DRA转基因小鼠中,I - Ab反应性CD4 + T细胞高频率的体外和体内证据。
J Immunol. 1997 Oct 15;159(8):3717-22.
7
A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.一类新的人类白细胞抗原II类受体可能起源于古老的人类物种。
J Biol Chem. 2014 Jan 10;289(2):639-53. doi: 10.1074/jbc.M113.515767. Epub 2013 Nov 8.
8
Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.鉴定 MHC Ⅱ类限制的 T 细胞对 MHC Ⅰ类结合结核分枝杆菌肽的反应性。
Immunology. 2011 Apr;132(4):482-91. doi: 10.1111/j.1365-2567.2010.03383.x. Epub 2011 Feb 7.
9
Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.体内半胱氨酸蛋白酶 G 裂解位点的掩蔽有助于主要组织相容性复合体 II 类分子的蛋白水解抗性。
Immunology. 2010 Jul;130(3):436-46. doi: 10.1111/j.1365-2567.2010.03247.x. Epub 2010 Mar 17.
10
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.一种与恒定链肽相关的突变型人类组织相容性白细胞抗原DR分子。
J Exp Med. 1994 Feb 1;179(2):541-9. doi: 10.1084/jem.179.2.541.

引用本文的文献

1
Delineating the Role of GxxxG Motif in Amyloidogenesis: A New Perspective in Targeting Amyloid-Beta Mediated AD Pathogenesis.阐明GxxxG基序在淀粉样蛋白形成中的作用:靶向β淀粉样蛋白介导的阿尔茨海默病发病机制的新视角
ACS Bio Med Chem Au. 2023 Oct 31;4(1):4-19. doi: 10.1021/acsbiomedchemau.3c00055. eCollection 2024 Feb 21.
2
Discovering immunoreceptor coupling and organization motifs.发现免疫受体偶联和组织基序。
Front Immunol. 2023 Sep 4;14:1253412. doi: 10.3389/fimmu.2023.1253412. eCollection 2023.